PRDM2 and cancer: SMYD3 activity was also correlated to the expression of RIZ1, a tumor suppressor protein silenced in a variety of cancers such as liver [61], breast [62], colon [63], gastric [64] and glioma [65] and whose expression is linked to G2/M arrest and induction of apoptosis in cancer cells [66].